Concepedia

A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

Antonio Jimeno, Keisuke Shirai, Minsig Choi, Janessa Laskin, Mark D. Kochenderfer, Alexander I. Spira, Vivian Jean M. Cline-Burkhardt, Eric Winquist, Diana F. Hausman, Luke Walker,

Annals of Oncology · 2014 · 99 citations · 36 references

DOIFull text

Open access

Concepts

References

36

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

Comprehensive molecular characterization of human colon and rectal cancer

Nature · 2012 · 8.7K citations · Full text

, , +16

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Nature · 2008 · 7.8K citations · Full text

, , +12

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata et al. · Science Translational Medicine · 2011 · 3.6K citations · Full text

, , +17

The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

Nicolas Stransky, Ann Marie Egloff, Aaron D. Tward et al. · Science · 2011 · 2.5K citations · Full text

, , +17